Hepatocellular carcinoma development requires hepatic stem cells with altered transforming growth factor and interleukin-6 signaling
✍ Scribed by Nicholas A. Shackel; Geoffrey W. McCaughan; Fiona J. Warner
- Book ID
- 102240068
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 165 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
✦ Synopsis
Cancer stem cells (CSCs) are critical for the initiation, propagation, and treatment resistance of multiple cancers. Yet functional interactions between specific signaling pathways in solid organ "cancer stem cells," such as those of the liver, remain elusive. We report that in regenerating human liver, two to four cells per 30,000-50,000 cells express stem cell proteins Stat3, Oct4, and Nanog, along with the prodifferentiation proteins TGF-beta-receptor type II (TBRII) and embryonic liver fodrin (ELF). Examination of human hepatocellular cancer (HCC) reveals cells that label with stem cell markers that have unexpectedly lost TBRII and ELF.
📜 SIMILAR VOLUMES
## Abstract Recent studies have identified epithelial cell populations in human livers that are similar to the “oval cells” and “transitional cells” seen in rat livers during the early stages of chemical car‐cinogenesis. It has been suggested that these cells might be precursors of hepatocytes and